Clinical Trials Directory

Trials / Completed

CompletedNCT01997879

Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers

An Open-label Study Assessing the Ocular and Systemic Safety and Systemic Absorption of AR-13324 Ophthalmic Solution, 0.02% in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Aerie Pharmaceuticals · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess systemic safety and absorption of AR-13324 in healthy volunteers.

Conditions

Interventions

TypeNameDescription
DRUGAR-13324 Ophthalmic Solution, 0.02%Eyedrop

Timeline

Start date
2013-11-01
Primary completion
2013-11-01
Completion
2013-11-01
First posted
2013-11-28
Last updated
2023-08-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01997879. Inclusion in this directory is not an endorsement.